Koa Wealth Management’s Connect Biopharma Holdings CNTB Stock Holding History

Koa Wealth Management’s Portfolio CNTB Stock Details CNTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$118K	Hold	49,600	–	–	0.08%	53
2026 Q1	$130K	Hold	49,600	–	–	0.09%	53
2025 Q4	$140K	Hold	49,600	–	–	0.1%	56
2025 Q3	$74.9K	Hold	49,600	–	–	0.06%	57
2025 Q2	$48.6K	Buy	+49,600	New	+$39.5K	0.04%	53

Other funds holding CNTB

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Koa Wealth Management's CNTB Position: Q2 2026 in Review

Koa Wealth Management held its Connect Biopharma Holdings (CNTB) position steady in Q2 2026 at 49,600 shares worth $118K. The position accounts for 0.08% of the portfolio, ranked #53.

Koa Wealth Management first reported a position in CNTB in Q2 2025 and has held it in 5 quarters since. The position peaked at $140K in Q4 2025. 6 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

Koa Wealth Management held 49,600 shares of Connect Biopharma Holdings worth $118K as of Q2 2026.
Koa Wealth Management left its Connect Biopharma Holdings share count unchanged in Q2 2026.
Connect Biopharma Holdings made up 0.08% of Koa Wealth Management's portfolio in Q2 2026, its #53 holding.
Koa Wealth Management first reported a position in Connect Biopharma Holdings in Q2 2025 and has held it in 5 quarters since.
Koa Wealth Management's Connect Biopharma Holdings position peaked at $140K in Q4 2025.
6 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Koa Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.